1987
DOI: 10.1192/bjp.151.6.824
|View full text |Cite
|
Sign up to set email alerts
|

In Vivo Assay for Neuroleptic Receptor Binding in the Striatum

Abstract: Using PET, we investigated the potency in six patients of therapeutic doses of neuroleptic drugs for preventing specific binding of trace doses of intravenously administered 76Br-labelled bromospiperone to corpus striatum in vivo. Measured receptor occupancy showed a clear-cut dose-dependent saturation curve with increasing daily oral dose of neuroleptics, indicating the validity and reliability of the method when used as an in vivo radioreceptor assay. Following drug withdrawal in eight patients, recovery to … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
19
0
1

Year Published

1989
1989
2002
2002

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 68 publications
(23 citation statements)
references
References 40 publications
(8 reference statements)
3
19
0
1
Order By: Relevance
“…With increasing dose of CP-88,059-1 there was a decrease in the binding potential (BP) of 11C-raclopride, indicating increasing central dopamine D2 receptor blockade. The results show that a single dose of between 20 and 40 mg CP-88,059-1 is likely to cause > 65% receptor occupancy -the degree associated with clinical doses of a variety of antipsychotic drugs (Cambon et al 1987;Farde et al 1988b). The correlation of the amount of CP-88,059-1 given or AUC{0-oo} of CP-88,059-1 with the PET derived measure of binding potential was greater than for the correlation with the prolactin response.…”
Section: Discussionmentioning
confidence: 85%
“…With increasing dose of CP-88,059-1 there was a decrease in the binding potential (BP) of 11C-raclopride, indicating increasing central dopamine D2 receptor blockade. The results show that a single dose of between 20 and 40 mg CP-88,059-1 is likely to cause > 65% receptor occupancy -the degree associated with clinical doses of a variety of antipsychotic drugs (Cambon et al 1987;Farde et al 1988b). The correlation of the amount of CP-88,059-1 given or AUC{0-oo} of CP-88,059-1 with the PET derived measure of binding potential was greater than for the correlation with the prolactin response.…”
Section: Discussionmentioning
confidence: 85%
“…If the kinetics of clozapine occupancy in primates reflect those in patients, this would suggest that patients receiving clozapine would show wide fluctuations in daily D 2 occupancy. On the other hand, less than 20% decrease of D 2 receptor occupancy is observed at around 24 h after a single dose of 2.0-7.5 mg haloperidol (Farde et al 1988;Nordström et al 1992), and it takes 7-12 days to return to the control level of binding after withdrawal of typical antipsychotics (Cambon et al 1987).…”
Section: Discussionmentioning
confidence: 99%
“…Following withdrawal of oral neuroleptics, return to normal receptor availability, as estimated by PET, is reported by Baron (1989) to occur within 5-15 days, or even within 3 days, as reported by Cambon (1987).…”
Section: Introductionmentioning
confidence: 86%